Pro-Dex, Inc. (NASDAQ:PDEX – Get Free Report) Director Raymond E. Cabillot sold 5,151 shares of the company’s stock in a transaction that occurred on Friday, March 14th. The shares were sold at an average price of $50.00, for a total value of $257,550.00. Following the completion of the sale, the director now owns 300,695 shares in the company, valued at $15,034,750. The trade was a 1.68 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Pro-Dex Price Performance
Shares of PDEX opened at $48.89 on Tuesday. Pro-Dex, Inc. has a 52-week low of $16.84 and a 52-week high of $59.60. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.44 and a current ratio of 2.58. The business’s 50 day moving average price is $39.79 and its two-hundred day moving average price is $38.48. The firm has a market cap of $159.43 million, a PE ratio of 24.32 and a beta of 0.68.
Pro-Dex (NASDAQ:PDEX – Get Free Report) last issued its quarterly earnings results on Thursday, January 30th. The medical instruments supplier reported $0.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.38 by $0.23. Pro-Dex had a return on equity of 21.68% and a net margin of 11.06%. On average, equities analysts anticipate that Pro-Dex, Inc. will post 2 EPS for the current year.
Hedge Funds Weigh In On Pro-Dex
Analysts Set New Price Targets
Separately, StockNews.com lowered Pro-Dex from a “buy” rating to a “hold” rating in a research note on Wednesday, March 12th.
Check Out Our Latest Stock Report on Pro-Dex
About Pro-Dex
Pro-Dex, Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets.
Featured Articles
- Five stocks we like better than Pro-Dex
- Investing in the High PE Growth Stocks
- Can TikTok Stock Picks Really Make You Rich?
- What Do S&P 500 Stocks Tell Investors About the Market?
- The “Quality” Rotation: Back to Basics Investing
- What is the S&P 500 and How It is Distinct from Other Indexes
- Occidental Petroleum: 4 Reasons to Love These Prices
Receive News & Ratings for Pro-Dex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro-Dex and related companies with MarketBeat.com's FREE daily email newsletter.